Amgen, Allergan say Avastin copycat succeeds in lung cancer study
 

Amgen, Allergan say Avastin copycat succeeds in lung cancer study
(Reuters) - Amgen Inc and Allergan Plc said their drug candidate for lung cancer was found as effective as Roche AG's Avastin in preventing disease progression and improving survival, in a late-stage study.
http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...so:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...so:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/lOzSUjqBUiY